Issued Patents All Time
Showing 1–16 of 16 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12172986 | Splicing modulator antibody-drug conjugates and methods of use | Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more | 2024-12-24 |
| 11945807 | Splicing modulator antibody-drug conjugates and methods of use | Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more | 2024-04-02 |
| 11833119 | Combination therapies for the treatment of hepatocellular carcinoma | Anand Selvaraj | 2023-12-05 |
| 11761045 | Splice variants associated with neomorphic SF3B1 mutants | Lihua Yu, Kian Huat Lim, Jacob D. Feala, Silvia Buonamici, Yoshiharu Mizui +4 more | 2023-09-19 |
| 11524009 | Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use | Daniel Aird, Laura Corson, Ping Zhu, Markus Warmuth, Silvia Buonamici +1 more | 2022-12-13 |
| 11357769 | Drug combinations for reducing cell viability and/or cell proliferation | Anand Selvaraj | 2022-06-14 |
| 11352348 | Splicing modulator antibody-drug conjugates and methods of use | Ermira Pazolli, Silvia Buonamici, Thiwanka Samarakoon, Sudeep Prajapati, Nathan Elliott Fishkin +13 more | 2022-06-07 |
| 11083722 | Combination therapies for the treatment of breast cancer | Craig D. Karr, Manav Korpal, Nathalie Rioux | 2021-08-10 |
| 10953013 | Biomarkers of response to NAE inhibitors | Cyril Benes, Stephen J. Blakemore, Jonathan L. Blank, Eric S. Lightcap, George J. Mulligan +2 more | 2021-03-23 |
| 10889866 | Splice variants associated with neomorphic SF3B1 mutants | Lihua Yu, Kian Huat Lim, Jacob D. Feala, Silvia Buonamici, Yoshiharu Mizui +4 more | 2021-01-12 |
| 10851065 | Tetrasubstituted alkene compounds and their use | Mark G. Bock, Ming-Hong Hao, Manav Korpal, Vijay Kumar Nyavanandi, Xiaoling Puyang +4 more | 2020-12-01 |
| 10745387 | Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof | Gregg F. Keaney, John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU +19 more | 2020-08-18 |
| 9827246 | Biomarkers of response to NAE inhibitors | Stephen J. Blakemore, Bin Li, George J. Mulligan, Matthew C. Schu | 2017-11-28 |
| 9796683 | Tetrasubstituted alkene compounds and their use | Mark G. Bock, Ming-Hong Hao, Manav Korpal, Vijay Kumar Nyavanandi, Xiaoling Puyang +4 more | 2017-10-24 |
| 9481669 | Pladienolide pyridine compounds and methods of use | Gregg F. Keaney, John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU +17 more | 2016-11-01 |
| 8980850 | Administration of a NEDD8-activating enzyme inhibitor and hypomethylating agent | — | 2015-03-17 |